Galactomannan derivative
Term · Oncology and biomedicine · MLC-T-ONC-013812
A carbohydrate polymer composed of mannose and galactose, with chemotherapeutic enhancing activity. Galactomannan derivative binds to galectins on cell surfaces and may promote the transport of certain chemotherapeutics, such as 5-fluorouracil (5-FU), into tumor cells. This may increase the antineoplastic effect of 5-FU when administered concomitantly. Galectins are carbohydrate-binding proteins, upregulated on the surface of certain types of tumor cells, and may mediate cell association, survival and metastasis.
| Identifier | MLC-T-ONC-013812 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | GD |
| Synonyms | 1,4-beta-D-galactomannan |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013812",
"term": "Galactomannan derivative",
"field": "Oncology and biomedicine",
"definition": "A carbohydrate polymer composed of mannose and galactose, with chemotherapeutic enhancing activity. Galactomannan derivative binds to galectins on cell surfaces and may promote the transport of certain chemotherapeutics, such as 5-fluorouracil (5-FU), into tumor cells. This may increase the antineoplastic effect of 5-FU when administered concomitantly. Galectins are carbohydrate-binding proteins, upregulated on the surface of certain types of tumor cells, and may mediate cell association, survival and metastasis.",
"abbreviation": "GD",
"synonyms": [
"1,4-beta-D-galactomannan"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/galactomannan-derivative/"
}
Record 7,688 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.